Friday, July 10, 2026

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 21 of 39
  1. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials
  2. Methylprednisolone (Injectable Form)

    Universal Integrated

    Unruptured Intracranial Aneurysms

    approved small molecule active

    1 trial
  3. Methylprednisolone and Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hepatitis

    approved small molecule active

    1 trial
  4. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial
  5. Metronidazole vaginal suppositories

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bacterial Vaginosis

    approved small molecule active

    1 trial
  6. MgSO4 plus Ropivacaine

    Hospital Authority, Hong Kong

    Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block

    approved small molecule completed

    1 trial
  7. Micafungin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aspergillosis

    approved small molecule terminated

    1 trial
  8. Midodrine HCl

    Takeda

    Orthostatic Hypotension

    approved small molecule completed

    1 trial
  9. Midodrine HCl

    Takeda

    Symptomatic Orthostatic Hypotension

    approved small molecule completed

    1 trial
  10. Midodrine Hydrochloride

    Takeda

    Hypotension, Orthostatic

    approved small molecule completed

    2 trials
  11. Mifepristone

    NORTHWEST BIOTHERAPEUTICS INC

    Pregnancy Related

    approved small molecule completed

    1 trial
  12. Mifepristone 300 MG [Korlym]

    CORCEPT THERAPEUTICS INC

    Hypercortisolism

    approved small molecule completed

    1 trial
  13. Mifepristone tablets

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Uterine Fibroid

    approved small molecule terminated

    1 trial
  14. Minocycline

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    approved small molecule completed

    1 trial
  15. Minocycline

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    2 trials
  16. Minoxidil lotion 1%

    Hospital Authority, Hong Kong

    Eyebrow Hypotrichosis

    approved small molecule completed

    1 trial
  17. Minoxidil lotion 2%

    Hospital Authority, Hong Kong

    Hypotrichosis of Eyebrows

    approved small molecule completed

    1 trial
  18. Misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Labor

    approved small molecule active

    1 trial
  19. Mitapivat

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    approved small molecule active

    2 trials
  20. Mixed amphetamine salts (ADDERALL XR)

    Takeda

    ADHD

    approved small molecule completed

    1 trial
  21. Mobile Surgical Vehicle Echocardiography-guided ASD closure Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ASD - Atrial Septal Defect

    approved other active

    1 trial
  22. Mometasone

    Universal Integrated

    Rhinitis, Allergic, Seasonal

    approved small molecule completed

    1 trial
  23. Mometasone Furoate Nasal Spray (MFNS)

    Universal Integrated

    Seasonal Allergic Rhinitis

    approved small molecule completed

    1 trial
  24. Montelukast

    The First People's Hospital of Lianyungang

    Sinusitis

    approved small molecule completed

    1 trial
  25. Monthly Review Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial
  26. Morphine

    COLLEGIUM PHARMACEUTICAL, INC

    ST-segment Elevation Myocardial Infarction

    approved small molecule completed

    1 trial
  27. Morphine

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    approved small molecule terminated

    1 trial
  28. Mounjaro solution for injection in pre-filled... for Obesity

    The George Institute

    Obesity

    approved small molecule active

    1 trial
  29. Moxonidine 0.2 MG

    Hospital Authority, Hong Kong

    Central Sympathetic Nervous System Diseases

    approved small molecule completed

    1 trial
  30. Mumps vaccine

    Sinovac Research and Development Co.,

    Mumps

    approved mab completed

    1 trial
  31. Mumps vaccine, Live (MV)

    Sinovac Research and Development Co.,

    Mumps

    approved mab active

    1 trial
  32. Myocardial perfusion imaging

    Aspire Biopharma Holdings

    Coronary Artery Disease

    approved other completed

    1 trial
  33. Myozyme 50 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease / glycogenosis type II / acid maltase deficiency

    approved small molecule active

    1 trial
  34. Myozyme powder for concentrate for solution f... for Pompe disease

    Disc Medicine

    Pompe disease

    approved small molecule active

    1 trial
  35. Mysimba 8 mg/90 mg prolonged-release tablets

    Disc Medicine

    Obesity, Obesity Surgery

    approved small molecule active

    1 trial
  36. N-acetycysteine (600mg twice daily)

    Kwong Wah Hospital

    COPD

    approved small molecule completed

    1 trial
  37. NAABAK eyedrops

    Laboratoire HRA Pharma

    Allergic Conjunctivitis

    approved small molecule completed

    1 trial
  38. NAC

    United Therapeutics Europe Ltd

    Effects of High Altitude

    approved small molecule terminated

    1 trial
  39. NESINA ACT TAB. 25/15mg

    Takeda

    Diabetes

    approved small molecule active

    1 trial
  40. NIVOLUMAB

    Disc Medicine

    Melanoma, Renal cell carcinoma

    approved small molecule active

    1 trial
  41. NL6220204217

    Disc Medicine

    HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.

    approved small molecule active

    1 trial
  42. NL65364.078.18

    Disc Medicine

    Strictures after esophageal atresia repair

    approved small molecule active

    1 trial
  43. NL71782.078.19

    Disc Medicine

    Pulmonary sarcoidosis

    approved small molecule active

    1 trial
  44. NL77315.078.21

    Disc Medicine

    Patients with coronary artery disease and an indication for PCI

    approved small molecule active

    1 trial
  45. NL77785.078.21

    Disc Medicine

    Complex regional pain syndrome

    approved small molecule active

    1 trial
  46. NN1436-7727

    NovoThirteen

    Type 2 diabetes

    approved small molecule active

    1 trial
  47. NN9536-7752

    NovoThirteen

    Obesity

    approved small molecule active

    1 trial
  48. NN9838-4968

    NovoThirteen

    Obesity and T2D

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.